Catalog name Description price
R-R-3062 Atranorin CAS No.479-20-9 Atranorin/CAS No.479-20-9 is a lichen secondary metabolite. Atranorin inhibits lung cancer cell motility and tumorigenesis by affecting AP-1, Wnt, and STAT signaling and suppressing RhoGTPase activity. price>
R-R-3063 (S)-JDQ-443 CAS No.2653994-10-4 (S)-JDQ-443/CAS No.2653994-10-4 is an isomer of JDQ-443 (HY-139612). JDQ-443 is an orally active, potent, selective, and covalent KRAS G12C inhibitor (extracted from patent WO2021120890A1). JDQ-443 shows antitumor activity. price>
R-R-3064 Rac1-IN-3 CAS No.380470-06-4 Rac1-IN-3 (Compound 2)/CAS No.380470-06-4 is a Rac1 inhibitor with an IC50 of 46.1 μM. price>
R-R-3065 (E/Z)-ZINC09659342 CAS No.591726-26-0 (E/Z)-ZINC09659342/CAS No.591726-26-0 is an inhibitor of Lbc-RhoA interaction. price>
R-R-3066 KRpep-2d TFA KRpep-2d (TFA) is a potent K-Ras inhibitor and inhibits proliferation of K-Ras-driven cancer cells. KRpep-2d can be used for cancer research. price>
R-R-3067 K-Ras G12C-IN-2 CAS No.1629267-75-9 K-Ras G12C-IN-2/CAS No.1629267-75-9 is an irreversible covalent K-Ras G12C inhibitor. price>
R-R-3068 K-Ras(G12C) inhibitor 9 CAS No.1469337-91-4 K-Ras (G12C) inhibitor 9/CAS No.1469337-91-4 is an allosteric inhibitor of the K-Ras (G12C). price>
R-R-3069 Deltarasin hydrochloride CAS No.1613404-76-4 Deltarasin hydrochloride/CAS No.1613404-76-4 is an inhibitor of KRAS-PDEδinteraction with Kd of 38 nM for binding to purified PDEδ. price>
R-R-3070 RBC10 CAS No.362503-73-9 RBC10/CAS No.362503-73-9 is an anti-cancer agent. RBC10 inhibits the binding of Ral to its effector RALBP1. RBC10 also inhibits Ral-mediated cell spreading of murine embryonic fibroblasts and anchorage-independent growth of human cancer cell lines. price>
R-R-3071 KRASG12D-IN-2 KRASG12D-IN-2 (compound 28) is a KRASG12D Inhibitor. KRASG12D-IN-1 has dose-dependent anti-tumor efficacy in the AsPC-1 xenograft mouse models with a tumor growth inhibition. price>